SCHEMBL7873330

SCHEMBL7873330

CNC(N)=NC(=O)c1cc2ccc(O)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.46
FLT3 P36888 7/20 0.45
ALOX15 P16050 1/20 0.45
CA2 P00918 1/20 0.41
PDGFRB P09619 3/20 0.41
KIT P10721 2/20 0.41
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
SMAD3 P84022 1/20 0.40
PDGFRA P16234 1/20 0.40
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
EIF4A3 P38919 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7881998 0.99 HRH4 (0.45) HRH4FLT3ALOX15CA2PDGFRB
SCHEMBL7873277 0.89 FLT3 (0.55) HRH4FLT3PDGFRBKITABL1
Hydrochloric Acid SCHEMBL7877524 0.88 FLT3 (0.54) HRH4FLT3PDGFRBKITABL1
SCHEMBL7873687 0.86 HRH4 (0.48) HRH4FLT3ALOX15PDGFRBPDGFRA
SCHEMBL7882077 0.86 FLT3 (0.48) FLT3ALOX15PDGFRBPDGFRAGRIN2D
Hydrochloric Acid SCHEMBL7880750 0.85 FLT3 (0.47) FLT3ALOX15PDGFRBPDGFRAGRIN2D
Hydrochloric Acid SCHEMBL7882164 0.85 HRH4 (0.47) HRH4FLT3ALOX15PLGPLAU
SCHEMBL7879684 0.85 ALOX15 (0.64) HRH4FLT3ALOX15PDGFRBPLG
Hydrochloric Acid SCHEMBL7884851 0.84 ALOX15 (0.63) HRH4FLT3ALOX15PDGFRBPLG
SCHEMBL7877581 0.83 KDM4E (0.54) FLT3PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed